Unintended HIV-1 Transmission to a Sex Partner in a Study of a Therapeutic Vaccine Candidate
- PMID: 30779842
- PMCID: PMC6603976
- DOI: 10.1093/infdis/jiz012
Unintended HIV-1 Transmission to a Sex Partner in a Study of a Therapeutic Vaccine Candidate
Abstract
We report a case of sexual transmission of human immunodeficiency virus (HIV) that occurred during treatment discontinuation in a therapeutic vaccine trial, following oral sex. Transmission occurred even though the index participant was an HIV/AIDS activist, particularly well informed about the risks and modalities of transmission. This case report highlights the risk of secondary transmission of HIV during cessation of treatment in HIV cure-related trials.
Keywords: HIV therapeutic vaccine; analytic treatment interruption; oral sex; secondary transmission.
© The Author(s) 2019. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com.
Comment in
-
Secondary HIV Infection and Mitigation in Cure-Related HIV Trials During Analytical Treatment Interruptions.J Infect Dis. 2019 Aug 30;220(7):1230-1231. doi: 10.1093/infdis/jiz262. J Infect Dis. 2019. PMID: 31505661 Free PMC article. No abstract available.
-
Re: Pre-Exposure Prophylaxis for Mitigating Risk of HIV Transmission During HIV Cure-Related Clinical Trials With a Treatment Interruption.J Infect Dis. 2019 Aug 30;220(7):1231-1233. doi: 10.1093/infdis/jiz263. J Infect Dis. 2019. PMID: 31505662 No abstract available.
-
Unintended HIV-1 Transmission to a Sex Partner in a Study of a Therapeutic Vaccine Candidate.J Infect Dis. 2019 Aug 30;220(7):1233-1234. doi: 10.1093/infdis/jiz264. J Infect Dis. 2019. PMID: 31505663 No abstract available.
-
Reply to Dee, and Johnson and Folayan.J Infect Dis. 2019 Aug 30;220(7):1234. doi: 10.1093/infdis/jiz265. J Infect Dis. 2019. PMID: 31505664 No abstract available.
References
-
- Levy Y, Lelièvre J-D, Perrier A, et al. . Preliminary safety results from VRI02 ANRS 149 Light (Lipopeptide and DNA GTU HIV Therapeutic Trial) [abstract P27.09]. Presented at: HIV Research for Prevention, Chicago, Illinois, 17–21 October 2016: https://www.abstractstosubmit.com/hivr4p2016/eposter/main.php?do=YToyOnt... Accessed 18 January 2019.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical